The comparative clinical pharmacology of vincristine and vindesine: does vindesine offer any advantage in clinical use?

S Joel - Cancer treatment reviews, 1995 - Elsevier
The vinca alkaloids have played an important role in the chemotherapy of malignant disease
for many years. As is often the case with therapeutic agents, their discovery was somewhat …

Pharmacokinetic, bioavailability, and feasibility study of oral vinorelbine in patients with solid tumors.

EK Rowinsky, DA Noe, DL Trump, EP Winer… - Journal of clinical …, 1994 - ascopubs.org
PURPOSE The feasibility of administering vinorelbine (Navelbine, Burroughs Wellcome Co,
Research Triangle Park, NC), a semisynthetic vinca alkaloid with broad activity, as a liquid …

Population pharmacokinetics model and limited sampling strategy for intravenous vinorelbine derived from phase I clinical trials

L Nguyen, B Tranchand, C Puozzo… - British journal of clinical …, 2002 - Wiley Online Library
Aims a) To characterize the pharmacokinetics of intravenous vinorelbine, b) to use a
population analysis for the identification of patient covariates that might appreciably …

Development of pegylated liposomal vinorelbine formulation using “post-insertion” technology

CL Li, JX Cui, CX Wang, L Zhang, YH Li… - International journal of …, 2010 - Elsevier
Prolonged vinorelbine exposure is correlated with improved antineoplastic effects, as
evidenced by increased response rate in patients receiving continuous infusion. The …

Nuclear Tubulin Enhances CXCR4 Transcription and Promotes Chemotaxis Through TCF12 Transcription Factor in human Hematopoietic Stem Cells

N Geng, Z Yu, X Zeng, D Xu, H Gao, M Yang… - Stem Cell Reviews and …, 2023 - Springer
Tubulins are cytoskeleton components in all eukaryotic cells and play crucial roles in various
cellular activities by polymerizing into dynamic microtubules. A subpopulation of tubulin has …

Vinorelbine-induced oxidative injury in human endothelial cells mediated by AMPK/PKC/NADPH/NF-κB pathways

KL Tsai, TH Chiu, MH Tsai, HY Chen, HC Ou - Cell biochemistry and …, 2012 - Springer
Vinorelbine tartrate (VNR), a semi-synthetic vinca alkaloid acquired from vinblastine, has
extensively been used as an anticancer agent. However, VNR-induced oxidative damage …

Current options in the treatment of non-small cell lung cancer

D Faulds - Drugs, 1992 - Springer
Non-small cell lung cancer (NSCLC) is a leading cause of cancer death in industrialised
countries, with an overall 5-year survival rate of less than 10%. Good patient performance …

The effects of food and divided dosing on the bioavailability of oral vinorelbine

EK Rowinsky, VS Lucas, ALY Hsieh, WA Wargin… - Cancer chemotherapy …, 1996 - Springer
The effects of food and divided dosing on the bioavailability of a liquid-filled gelatin capsule
formulation of vinorelbine (Navelbine), a semisynthetic vinca alkaloid with broad clinical …

Carboplatin and vinorelbine in advanced non-small-cell lung cancer

P Pronzato, E Ghio, PL Losardo, M Landucci… - Cancer chemotherapy …, 1996 - Springer
A total of 32 patients with advanced non-small-cell lung cancer were treated with carboplatin
(350 mg/m 2, day 1) and vinorelbine (days 1 and 8) every 28 days. A response rate of …

Efficacy and toxicity of vinorelbine-carboplatin combination in the treatment of advanced adenocarcinoma or large-cell carcinoma of the lung

A Masotti, G Borzellino, G Zannini, E Laterza… - Tumori …, 1995 - journals.sagepub.com
Aims and background The aim of the study was to assess the activity and toxicity of the
vinorelbine-carboplatin combination in advanced adenocarcinoma or large-cell carcinoma …